AG0033SJ

700874-72-2 | 4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide

AG0033SJ

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	700874-72-2
Catalog Number	AG0033SJ(AGN-PC-0MYLJ5)
Chemical Name	4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide
IUPAC Name	4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide
InChI	InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28)
InChI Key	IVRXNBXKWIJUQB-UHFFFAOYSA-N
MDL Number	MFCD12923319
Molecular Formula	C22H19N5O
Molecular Weight	369.4192
SMILES	Cc1cccc(n1)c1nn2c(c1c1ccnc3c1cc(cc3)C(=O)N)CCC2
UNII	3OKH1W5LZE
Synonyms	4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo(1,2-b)pyrazol-3-yl)quinoline-6-carboxylic acid amide, galunisertib, LY 2157299, LY-2157299, LY2157299, Galunisertib, 700874-72-2, LY2157299, LY 2157299, LY-2157299, UNII-3OKH1W5LZE, 4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide, Galunisertib (LY2157299), 3OKH1W5LZE, AK-79916, 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide, 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo-[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide, 4-[2-(6-methylpyridin-2-yl)-4H,5H,6H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide, 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide, 6-Quinolinecarboxamide, 4-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-, Galunisertib [USAN:INN], galunisertibum, 6-Quinolinecarboxamide, 4-(5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-, Galunisertib (USAN), PubChem22590, ly2157299(galunisertib), 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo(1,2-b)pyrazol-3-yl)quinoline-6-carboxylic acid amide, GTPL7797, CHEMBL2364611, SCHEMBL12922153, CTK2G3146, DTXSID00220362, EX-A009, QCR-234, CHEBI:137064, HMS3655D14, AOB87326, BCP02173, EBD30286, ZINC3959536, BDBM50015640, MFCD12923319, s2230, AKOS022175280, CS-0474, DB11911, EX-8675, RL04686, SB16483, LYL-2157299, NCGC00384167-07, AJ-47534, AS-42940, BC638676, CJ-11234, HY-13226, inhibitor 15d [PMID: 18314943], SC-85597, AB0033807, AX8280550, FT-0741808, SW219460-1, X7574, D10437, W-5548, A836766, J-514250, LY-2157299,LY 2157299, 700874-72-2, 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide, AldrichCPR, 4-[2-(6-methyl-2-pyridinyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide, 4-[2-(6-Methyl-2-Pyridinyl)-5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazol-3-Yl]-6-Quinolinecarboxamideorly215, 4-[2-(6-Methyl-pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxylic acid amide, 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[2,1-e]pyrazol-3-yl]quinoline-6-carboxamide, Galunisertib [USAN], cc-8, D06TFI, C22H19N5O, ACN-029581, CID10090485, A8348, A11017, C557799, Galunisertib, 98%, a potent TGF-beta receptor I (TbetaRI) inhibitor - 10MG 10mg, 4-[7-(6-methylpyridin-2-yl)-1,8-diazabicyclo[3.3.0]octa-5,7-dien-6-yl]quinoline-6-carboxamide,

Complexity	585
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	369.159g/mol
Formal Charge	0
Heavy Atom Count	28
Hydrogen Bond Acceptor Count	4
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	369.428g/mol
Monoisotopic Mass	369.159g/mol
Rotatable Bond Count	3
Topological Polar Surface Area	86.7A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	2.4

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H302-H315-H319-H332-H335
Packing Group	Ⅲ
Precautionary statements	P261-P280-P305+P351+P338
UN Code	UN 2811

Certificate of Analysis

Lot Number